{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-012885","form_type":"8-K","ticker":"ROIV","cik":"0001635088","company_name":"Roivant Sciences Ltd.","filed_at":"2026-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.629104+00:00","generated_at":"2026-05-15T07:51:14.874468+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Batoclimab TED Phase 3 misses endpoint; Roivant starts brepocitinib LPP trial; $4.3B cash","bullets":["Preliminary cash, cash equivalents and marketable securities as of Mar 31, 2026: ~$4.3B.","Repurchased 3,956,362 common shares for ~$109.7M in Q4 fiscal 2026.","Immunovant's two Phase 3 studies of batoclimab in TED failed to meet primary endpoint of ≥2mm proptosis responder rate at Week 24.","Priovant began Phase 2b/3 trial of brepocitinib in lichen planopilaris; first subjects enrolled Mar 2026.","Brepocitinib NDA for dermatomyositis granted Priority Review; PDUFA target in Q3 calendar 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-012885","json":"https://secwatch.observer/filing/0001140361-26-012885.json","markdown":"https://secwatch.observer/filing/0001140361-26-012885.md","text":"https://secwatch.observer/filing/0001140361-26-012885.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126012885/0001140361-26-012885-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635088/000114036126012885/ef20069685_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:51:14.874468+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}